Inova Health Care Services
Clinical trials sponsored by Inova Health Care Services, explained in plain language.
-
Personalized heparin calculator aims to speed up clot treatment
Disease control OngoingThis study tests whether using a patient's gender, weight, and kidney function to calculate the starting dose of the blood thinner heparin gets patients to the right level faster than the standard flat rate. About 145 adults with blood clots, atrial fibrillation, or mechanical he…
Phase: PHASE4 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Blood-Guided chemo dosing study for colon cancer withdrawn
Disease control TerminatedThis pilot study aimed to see if adjusting the dose of the chemotherapy drug 5-FU based on its concentration in the blood could improve treatment for metastatic colorectal cancer. The study was withdrawn before enrolling any participants. It was designed for adults with metastati…
Phase: PHASE2 • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New pacemaker study aims to ease heart failure symptoms
Disease control OngoingThis study tests if a special heart pacing device (CRT) can improve heart function and reduce symptoms in people with mild heart failure and a specific type of heart block (LBBB). About 21 adults with mild heart failure will receive the device. The goal is to see if the device he…
Phase: NA • Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Hope on video: new study tests positive messages for brain injury recovery
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing whether a short educational video that gives positive reassurance can improve recovery in people with mild traumatic brain injury (mTBI). Researchers will enroll 229 participants aged 13-21 who were diagnosed with mTBI in the emergency department. The goal i…
Phase: NA • Sponsor: Inova Health Care Services • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:05 UTC